# Central Plains Bancshares, Inc.: overview CPBI · Nasdaq · CIK 1979332 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31 Pages: [Overview](/companies/cpbi.md) · [Financials](/companies/cpbi/financials.md) · [Filings](/companies/cpbi/filings.md) · [Insiders](/companies/cpbi/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.25](/filings/0001193125-25-280272.md) | [0.25](/filings/0001193125-26-046679.md) | not reported | [0.26](/filings/0001193125-26-346968.md) | [0.23](/filings/0001193125-25-280272.md) | [0.31](/filings/0001193125-26-046679.md) | not reported | [0.39](/filings/0001193125-26-346968.md) | | Free cash flow | $k | [(975) d](/filings/0001193125-25-280272.md) | [(1,480) d](/filings/0001193125-26-046679.md) | [(647) d](/filings/0001193125-26-275962.md) | [(766)](/filings/0001193125-26-346968.md) | [888 d](/filings/0001193125-25-280272.md) | [2,227 d](/filings/0001193125-26-046679.md) | [3,271 d](/filings/0001193125-26-275962.md) | [(200)](/filings/0001193125-26-346968.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [2.19](/filings/0000950170-25-090434.md) | [0.96](/filings/0001193125-26-275962.md) | [1.05](/filings/0001193125-26-275962.md) | | Free cash flow | $k | [4,171](/filings/0000950170-24-076246.md) | [3,427](/filings/0000950170-25-090434.md) | [(3,067)](/filings/0001193125-26-275962.md) | [5,808](/filings/0001193125-26-275962.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cpbi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [STILWELL VALUE LLC](/funds/1397076.md) | 2026-06-30 | $7.7m | 406,874 | | Added +39,973 | | [GRAHAM CAPITAL WEALTH MANAGEMENT, LLC](/funds/1907528.md) | 2026-06-30 | $3.4m | 176,072 | | Reduced −1,580 | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $3.1m | 165,007 | | Unchanged | | [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $3.0m | 158,097 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.9m | 153,638 | | Reduced −137 | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $2.3m | 134,218 | | Added +5,669 | | [Minerva Advisors LLC](/funds/1541536.md) | 2026-06-30 | $934.7k | 49,117 | | Unchanged | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $701.6k | 36,846 | | Added +673 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $460.5k | 24,200 | | Added +300 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $357.1k | 18,766 | | Added +137 | ## Recent filings [All 98 filings](/companies/cpbi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-23 | 15:54 ET | [8-K](/filings/0000943374-26-000419.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000943374-26-000419 | | 2026-09-10 | 11:46 ET | [8-K](/filings/0001193125-26-387526.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-387526 | | 2026-08-28 | 16:30 ET | [8-K](/filings/0001193125-26-374605.md) | 5.07 Shareholder vote results | 0001193125-26-374605 | | 2026-08-12 | 16:30 ET | [10-Q](/filings/0001193125-26-346968.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346968 | | 2026-07-30 | 09:00 ET | [8-K](/filings/0000943374-26-000338.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000943374-26-000338 | | 2026-07-14 | 09:15 ET | [8-K](/filings/0000943374-26-000266.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000943374-26-000266 | | 2026-07-09 | 09:02 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001783.md) | Ownership report, active investor, amended | 0000921895-26-001783 | | 2026-07-09 | 09:00 ET | [8-K](/filings/0000943374-26-000259.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000943374-26-000259 | | 2026-06-23 | 17:55 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001654.md) | Ownership report, active investor, amended | 0000921895-26-001654 | | 2026-06-18 | 16:30 ET | [10-K](/filings/0001193125-26-275962.md) | Annual report, period 2026-03-31 | 0001193125-26-275962 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001193125-26-275962.md), filed Jun 18, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1979332 - Tickers: CPBI - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.